Similar Items: Hippo-YAP/TAZ Signaling in Hematological Malignancies: Molecular Mechanisms, Pathway Crosstalk and Therapeutic Potential
- Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer
- Early Myelosuppression Secondary to Linezolid Use in the Context of Hematologic Malignancy
- Colorectal Cancer Progression and Bone Metastasis: Molecular Mechanisms, Tumor Microenvironment, and Tumor-Bone Crosstalk
- SDC1 Knockdown Suppresses Malignant Phenotypes of Breast Cancer by Modulating the MAPK Signaling Pathway
- Survival of Hematologic Malignancy In Patients With Early‐Stage Chronic Kidney Disease (SHIP‐CKD)
- Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted Therapy